INM vs TRV · rev $4.9M vs P/E 14, rev $12.15B
InMed Pharmaceuticals Inc (INM) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
INM currently screens at market cap $5.2M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the INM and TRV stock pages for the full models.
Not investment advice.